E-commerce Channel Development

About Alliance Pharmaceuticals

Alliance Pharmaceuticals has undergone a definitive transformation, completing the sale of its pharmaceutical division in January 2026 to become a focused, international consumer healthcare company. Its mission is to empower people to make a positive difference to their health by commercializing a portfolio of trusted brands like Kelo-Cote™ and Nizoral™. The company's growth strategy is three-pronged: driving organic growth through brand investment and geographic expansion, pursuing related innovation, and selectively acquiring complementary brands, all executed via an asset-light operational model.

Therapeutic Areas